[ad_1] CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ — Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through…